when will oral semaglutide be available Optimal dosing and administration instructions for GLP-1 now available as tablets?

Protein and Nutrients Nuts and seeds deliver protein, fiber, vitamin E, magnesium, zinc, and more

Womans World wants to hear YOUR experiences with G-Plans, or your experiences with prescription weight loss or telehealth in general

Does Zeeglow Max Soap help lighten dark spots, pigmentation, and acne marks

GLP-1 receptor agonists may be appropriate for individuals who: Have a body mass index (BMI) of 35 kg/m or higher (or lower thresholds32.5 kg/m or abovefor people from Black, Asian, and other minority ethnic groups) and would benefit from weight loss Have established cardiovascular disease or are at high cardiovascular risk (certain GLP-1 receptor agonists have demonstrated cardiovascular benefits in clinical trials) Have chronic kidney disease (CKD) or heart failure, where specific agents may offer additional protection Require additional glucose-lowering therapy but wish to avoid weight gain associated with some other diabetes medicines Cannot tolerate or have contraindications to other glucose-lowering therapies NICE NG28 continuation criteria : GLP-1 receptor agonist therapy should be continued beyond 6 months only if the person has had a beneficial metabolic response , defined as a reduction of at least 11 mmol/mol (1.0%) in HbA1c and a weight loss of at least 3% of initial body weight

2026 Jan 29;19(2):235